ID   NFU1_HUMAN              Reviewed;         254 AA.
AC   Q9UMS0; B4DUL9; Q53QE5; Q6VNZ8; Q7Z5B1; Q7Z5B2; Q9Y322;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   18-JUN-2025, entry version 192.
DE   RecName: Full=NFU1 iron-sulfur cluster scaffold homolog, mitochondrial;
DE   AltName: Full=HIRA-interacting protein 5 {ECO:0000303|PubMed:11342215};
DE   Flags: Precursor;
GN   Name=NFU1; Synonyms=HIRIP5 {ECO:0000303|PubMed:11342215};
GN   ORFNames=CGI-33 {ECO:0000303|PubMed:10810093};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Myeloid leukemia cell;
RX   PubMed=11342215; DOI=10.1016/s0167-4781(00)00300-6;
RA   Lorain S., Lecluse Y., Scamps C., Mattei M.-G., Lipinski M.;
RT   "Identification of human and mouse HIRA-interacting protein-5 (HIRIP5), two
RT   mammalian representatives in a family of phylogenetically conserved
RT   proteins with a role in the biogenesis of Fe/S proteins.";
RL   Biochim. Biophys. Acta 1517:376-383(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH EPM2A, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND VARIANT LYS-25.
RC   TISSUE=Brain;
RX   PubMed=12915448; DOI=10.1093/hmg/ddg253;
RA   Ganesh S., Tsurutani N., Suzuki T., Ueda K., Agarwala K.L., Osada H.,
RA   Delgado-Escueta A.V., Yamakawa K.;
RT   "The Lafora disease gene product laforin interacts with HIRIP5, a
RT   phylogenetically conserved protein containing a NifU-like domain.";
RL   Hum. Mol. Genet. 12:2359-2368(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12886008; DOI=10.1073/pnas.1732541100;
RA   Tong W.-H., Jameson G.N.L., Huynh B.H., Rouault T.A.;
RT   "Subcellular compartmentalization of human Nfu, an iron-sulfur cluster
RT   scaffold protein, and its ability to assemble a [4Fe-4S] cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:9762-9767(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   LYS-25.
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INVOLVEMENT IN MMDS1.
RX   PubMed=21944046; DOI=10.1016/j.ajhg.2011.08.011;
RA   Cameron J.M., Janer A., Levandovskiy V., Mackay N., Rouault T.A.,
RA   Tong W.H., Ogilvie I., Shoubridge E.A., Robinson B.H.;
RT   "Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a
RT   fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase
RT   enzymes.";
RL   Am. J. Hum. Genet. 89:486-495(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   INTERACTION WITH BOLA3.
RX   PubMed=27532772; DOI=10.7554/elife.16673;
RA   Uzarska M.A., Nasta V., Weiler B.D., Spantgar F., Ciofi-Baffoni S.,
RA   Saviello M.R., Gonnelli L., Muehlenhoff U., Banci L., Lill R.;
RT   "Mitochondrial Bol1 and Bol3 function as assembly factors for specific
RT   iron-sulfur proteins.";
RL   Elife 5:0-0(2016).
RN   [15]
RP   INTERACTION WITH HSPA9.
RX   PubMed=26702583; DOI=10.1016/j.mito.2015.12.005;
RA   Shan Y., Cortopassi G.;
RT   "Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-
RT   sulfur cluster assembly.";
RL   Mitochondrion 26:94-103(2016).
RN   [16]
RP   STRUCTURE BY NMR OF 59-155, SUBUNIT, AND FUNCTION.
RX   PubMed=27818104; DOI=10.1016/j.str.2016.08.020;
RA   Cai K., Liu G., Frederick R.O., Xiao R., Montelione G.T., Markley J.L.;
RT   "Structural/functional properties of human NFU1, an intermediate [4Fe-4S]
RT   carrier in human mitochondrial iron-sulfur cluster biogenesis.";
RL   Structure 24:2080-2091(2016).
RN   [17]
RP   VARIANT MMDS1 CYS-208.
RX   PubMed=22077971; DOI=10.1016/j.ajhg.2011.10.005;
RA   Navarro-Sastre A., Tort F., Stehling O., Uzarska M.A., Arranz J.A.,
RA   Del Toro M., Labayru M.T., Landa J., Font A., Garcia-Villoria J.,
RA   Merinero B., Ugarte M., Gutierrez-Solana L.G., Campistol J.,
RA   Garcia-Cazorla A., Vaquerizo J., Riudor E., Briones P., Elpeleg O.,
RA   Ribes A., Lill R.;
RT   "A fatal mitochondrial disease is associated with defective NFU1 function
RT   in the maturation of a subset of mitochondrial Fe-S proteins.";
RL   Am. J. Hum. Genet. 89:656-667(2011).
RN   [18]
RP   VARIANTS MMDS1 ARG-189 AND PHE-210.
RX   PubMed=25477904; DOI=10.3389/fgene.2014.00412;
RA   Invernizzi F., Ardissone A., Lamantea E., Garavaglia B., Zeviani M.,
RA   Farina L., Ghezzi D., Moroni I.;
RT   "Cavitating leukoencephalopathy with multiple mitochondrial dysfunction
RT   syndrome and NFU1 mutations.";
RL   Front. Genet. 5:412-412(2014).
RN   [19]
RP   VARIANTS MMDS1 PRO-21; TRP-182; ARG-189; ARG-190 AND CYS-208, AND
RP   CHARACTERIZATION OF VARIANTS MMDS1 PRO-21; TRP-182 AND CYS-208.
RX   PubMed=25918518; DOI=10.3389/fgene.2015.00123;
RA   Ahting U., Mayr J.A., Vanlander A.V., Hardy S.A., Santra S., Makowski C.,
RA   Alston C.L., Zimmermann F.A., Abela L., Plecko B., Rohrbach M.,
RA   Spranger S., Seneca S., Rolinski B., Hagendorff A., Hempel M., Sperl W.,
RA   Meitinger T., Smet J., Taylor R.W., Van Coster R., Freisinger P.,
RA   Prokisch H., Haack T.B.;
RT   "Clinical, biochemical, and genetic spectrum of seven patients with NFU1
RT   deficiency.";
RL   Front. Genet. 6:123-123(2015).
RN   [20]
RP   VARIANT MMDS1 ARG-189, CHARACTERIZATION OF VARIANT MMDS1 ARG-189,
RP   MUTAGENESIS OF GLY-189, AND FUNCTION.
RX   PubMed=28906594; DOI=10.1111/febs.14271;
RA   Wesley N.A., Wachnowsky C., Fidai I., Cowan J.A.;
RT   "Understanding the molecular basis for multiple mitochondrial dysfunctions
RT   syndrome 1 (MMDS1): impact of a disease-causing Gly189Arg substitution on
RT   NFU1.";
RL   FEBS J. 284:3838-3848(2017).
RN   [21]
RP   CHARACTERIZATION OF VARIANT MMDS1 CYS-208.
RX   PubMed=28161430; DOI=10.1016/j.jmb.2017.01.021;
RA   Wachnowsky C., Wesley N.A., Fidai I., Cowan J.A.;
RT   "Understanding the Molecular Basis of Multiple Mitochondrial Dysfunctions
RT   Syndrome 1 (MMDS1)-Impact of a Disease-Causing Gly208Cys Substitution on
RT   Structure and Activity of NFU1 in the Fe/S Cluster Biosynthetic Pathway.";
RL   J. Mol. Biol. 429:790-807(2017).
RN   [22]
RP   VARIANTS SPG93 SER-88; VAL-99; PRO-100; GLY-101; ALA-121; PRO-133; ARG-183;
RP   ARG-189; PHE-210 AND LEU-241, AND INVOLVEMENT IN SPG93.
RX   PubMed=36256512; DOI=10.1002/acn3.51679;
RA   Kaiyrzhanov R., Zaki M.S., Lau T., Sen S., Azizimalamiri R., Zamani M.,
RA   Sayin G.Y., Hilander T., Efthymiou S., Chelban V., Brown R., Thompson K.,
RA   Scarano M.I., Ganesh J., Koneev K., Guelacar I.M., Person R., Sadykova D.,
RA   Maidyrov Y., Seifi T., Zadagali A., Bernard G., Allis K., Elloumi H.Z.,
RA   Lindy A., Taghiabadi E., Verma S., Logan R., Kirmse B., Bai R.,
RA   Khalaf S.M., Abdel-Hamid M.S., Sedaghat A., Shariati G., Issa M.,
RA   Zeighami J., Elbendary H.M., Brown G., Taylor R.W., Galehdari H.,
RA   Gleeson J.J., Carroll C.J., Cowan J.A., Moreno-De-Luca A., Houlden H.,
RA   Maroofian R.;
RT   "Phenotypic continuum of NFU1-related disorders.";
RL   Ann. Clin. Transl. Neurol. 9:2025-2035(2022).
CC   -!- FUNCTION: Iron-sulfur cluster scaffold protein which can assemble [4Fe-
CC       4S] clusters and deliver them to target proteins.
CC       {ECO:0000269|PubMed:12886008, ECO:0000269|PubMed:27818104,
CC       ECO:0000269|PubMed:28906594}.
CC   -!- SUBUNIT: Monomer and homohexamer; the apo-NFU1 is a monomer, while the
CC       holo-NFU1 is a hexamer composed of a trimer of dimer that is probably
CC       linked by some 4Fe-4S cluster (PubMed:27818104). Interacts with HIRA
CC       and EPM2A/laforin (PubMed:12915448). Interacts with BOLA3
CC       (PubMed:27532772). Interacts with HSPA9 (PubMed:26702583).
CC       {ECO:0000269|PubMed:12915448, ECO:0000269|PubMed:26702583,
CC       ECO:0000269|PubMed:27532772, ECO:0000269|PubMed:27818104}.
CC   -!- INTERACTION:
CC       Q9UMS0; Q6RW13: AGTRAP; NbExp=3; IntAct=EBI-725252, EBI-741181;
CC       Q9UMS0; P02654: APOC1; NbExp=3; IntAct=EBI-725252, EBI-1220105;
CC       Q9UMS0; P55056: APOC4; NbExp=3; IntAct=EBI-725252, EBI-18302142;
CC       Q9UMS0; Q9Y3E2: BOLA1; NbExp=2; IntAct=EBI-725252, EBI-1049556;
CC       Q9UMS0; Q53S33: BOLA3; NbExp=2; IntAct=EBI-725252, EBI-12086950;
CC       Q9UMS0; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-725252, EBI-739580;
CC       Q9UMS0; Q9UHD4: CIDEB; NbExp=3; IntAct=EBI-725252, EBI-7062247;
CC       Q9UMS0; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-725252, EBI-11522780;
CC       Q9UMS0; P38432: COIL; NbExp=3; IntAct=EBI-725252, EBI-945751;
CC       Q9UMS0; Q9BSY9: DESI2; NbExp=3; IntAct=EBI-725252, EBI-12878374;
CC       Q9UMS0; Q9Y680: FKBP7; NbExp=3; IntAct=EBI-725252, EBI-3918971;
CC       Q9UMS0; P21741: MDK; NbExp=3; IntAct=EBI-725252, EBI-722444;
CC       Q9UMS0; Q6PF18: MORN3; NbExp=3; IntAct=EBI-725252, EBI-9675802;
CC       Q9UMS0; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-725252, EBI-17589229;
CC       Q9UMS0; Q9H190: SDCBP2; NbExp=3; IntAct=EBI-725252, EBI-742426;
CC       Q9UMS0; Q9UBB9: TFIP11; NbExp=6; IntAct=EBI-725252, EBI-1105213;
CC       Q9UMS0; P36406: TRIM23; NbExp=3; IntAct=EBI-725252, EBI-740098;
CC       Q9UMS0; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-725252, EBI-4395732;
CC       Q9UMS0; Q9BUG6: ZSCAN5A; NbExp=3; IntAct=EBI-725252, EBI-8836980;
CC       Q9UMS0; Q9Q2G4: ORF; Xeno; NbExp=3; IntAct=EBI-725252, EBI-6248094;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion. Cytoplasm, cytosol.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UMS0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UMS0-2; Sequence=VSP_041224;
CC       Name=3;
CC         IsoId=Q9UMS0-3; Sequence=VSP_041225;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expression in adult lung is weak
CC       compared to fetal lung. {ECO:0000269|PubMed:12915448}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryo and adult.
CC       {ECO:0000269|PubMed:12915448}.
CC   -!- DISEASE: Multiple mitochondrial dysfunctions syndrome 1 (MMDS1)
CC       [MIM:605711]: A severe disorder of systemic energy metabolism,
CC       resulting in weakness, respiratory failure, lack of neurologic
CC       development, lactic acidosis, hyperglycinemia and early death. Some
CC       patients show failure to thrive, pulmonary hypertension, hypotonia and
CC       irritability. Biochemical features include severe combined deficiency
CC       of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and
CC       reduction in activity of mitochondrial respiratory chain complexes.
CC       {ECO:0000269|PubMed:21944046, ECO:0000269|PubMed:22077971,
CC       ECO:0000269|PubMed:25477904, ECO:0000269|PubMed:25918518,
CC       ECO:0000269|PubMed:28161430, ECO:0000269|PubMed:28906594}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Spastic paraplegia 93, autosomal recessive (SPG93)
CC       [MIM:620938]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness and
CC       spasticity of the lower limbs. Rate of progression and the severity of
CC       symptoms are quite variable. Initial symptoms may include difficulty
CC       with balance, weakness and stiffness in the legs, muscle spasms, and
CC       dragging the toes when walking. In some forms of the disorder, bladder
CC       symptoms (such as incontinence) may appear, or the weakness and
CC       stiffness may spread to other parts of the body. Some SPG93 patients
CC       have neurodevelopmental delay with severe hypotonia.
CC       {ECO:0000269|PubMed:36256512}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NifU family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD27742.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAY14828.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAG36716.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB53015.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ132584; CAB53015.1; ALT_INIT; mRNA.
DR   EMBL; AY335194; AAQ73784.1; -; mRNA.
DR   EMBL; AY286306; AAP92372.1; -; mRNA.
DR   EMBL; AY286307; AAP92373.1; -; mRNA.
DR   EMBL; AF132967; AAD27742.1; ALT_FRAME; mRNA.
DR   EMBL; AK314004; BAG36716.1; ALT_INIT; mRNA.
DR   EMBL; AK300700; BAG62381.1; -; mRNA.
DR   EMBL; DB304061; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC114772; AAY14828.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471053; EAW99849.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99850.1; -; Genomic_DNA.
DR   EMBL; BC113692; AAI13693.1; -; mRNA.
DR   EMBL; BC113694; AAI13695.1; -; mRNA.
DR   CCDS; CCDS33217.1; -. [Q9UMS0-1]
DR   CCDS; CCDS42694.1; -. [Q9UMS0-2]
DR   CCDS; CCDS46315.1; -. [Q9UMS0-3]
DR   RefSeq; NP_001002755.1; NM_001002755.4. [Q9UMS0-1]
DR   RefSeq; NP_001002756.1; NM_001002756.2. [Q9UMS0-2]
DR   RefSeq; NP_001361213.1; NM_001374284.1. [Q9UMS0-3]
DR   RefSeq; NP_056515.2; NM_015700.4. [Q9UMS0-3]
DR   RefSeq; XP_016859297.1; XM_017003808.1.
DR   RefSeq; XP_047299895.1; XM_047443939.1. [Q9UMS0-3]
DR   PDB; 2LTM; NMR; -; A=59-155.
DR   PDB; 2M5O; NMR; -; A=162-247.
DR   PDBsum; 2LTM; -.
DR   PDBsum; 2M5O; -.
DR   AlphaFoldDB; Q9UMS0; -.
DR   BMRB; Q9UMS0; -.
DR   SASBDB; Q9UMS0; -.
DR   SMR; Q9UMS0; -.
DR   BioGRID; 118095; 57.
DR   FunCoup; Q9UMS0; 2527.
DR   IntAct; Q9UMS0; 29.
DR   MINT; Q9UMS0; -.
DR   STRING; 9606.ENSP00000387219; -.
DR   GlyGen; Q9UMS0; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UMS0; -.
DR   MetOSite; Q9UMS0; -.
DR   PhosphoSitePlus; Q9UMS0; -.
DR   BioMuta; NFU1; -.
DR   DMDM; 205371805; -.
DR   jPOST; Q9UMS0; -.
DR   MassIVE; Q9UMS0; -.
DR   PaxDb; 9606-ENSP00000387219; -.
DR   PeptideAtlas; Q9UMS0; -.
DR   ProteomicsDB; 85204; -. [Q9UMS0-1]
DR   ProteomicsDB; 85205; -. [Q9UMS0-2]
DR   ProteomicsDB; 85206; -. [Q9UMS0-3]
DR   Pumba; Q9UMS0; -.
DR   Antibodypedia; 48139; 46 antibodies from 18 providers.
DR   DNASU; 27247; -.
DR   Ensembl; ENST00000303698.7; ENSP00000306965.3; ENSG00000169599.13. [Q9UMS0-3]
DR   Ensembl; ENST00000394305.5; ENSP00000377842.1; ENSG00000169599.13. [Q9UMS0-2]
DR   Ensembl; ENST00000410022.7; ENSP00000387219.3; ENSG00000169599.13. [Q9UMS0-1]
DR   Ensembl; ENST00000462320.5; ENSP00000418598.1; ENSG00000169599.13. [Q9UMS0-2]
DR   GeneID; 27247; -.
DR   KEGG; hsa:27247; -.
DR   MANE-Select; ENST00000410022.7; ENSP00000387219.3; NM_001002755.4; NP_001002755.1.
DR   UCSC; uc002sfj.4; human. [Q9UMS0-1]
DR   AGR; HGNC:16287; -.
DR   CTD; 27247; -.
DR   DisGeNET; 27247; -.
DR   GeneCards; NFU1; -.
DR   HGNC; HGNC:16287; NFU1.
DR   HPA; ENSG00000169599; Low tissue specificity.
DR   MalaCards; NFU1; -.
DR   MIM; 605711; phenotype.
DR   MIM; 608100; gene.
DR   MIM; 620938; phenotype.
DR   OpenTargets; ENSG00000169599; -.
DR   Orphanet; 401869; Multiple mitochondrial dysfunctions syndrome type 1.
DR   VEuPathDB; HostDB:ENSG00000169599; -.
DR   eggNOG; KOG2358; Eukaryota.
DR   GeneTree; ENSGT00390000011296; -.
DR   HOGENOM; CLU_060555_0_2_1; -.
DR   InParanoid; Q9UMS0; -.
DR   OMA; AIMEHYM; -.
DR   OrthoDB; 565552at2759; -.
DR   PAN-GO; Q9UMS0; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9UMS0; -.
DR   PathwayCommons; Q9UMS0; -.
DR   Reactome; R-HSA-9857492; Protein lipoylation.
DR   SignaLink; Q9UMS0; -.
DR   BioGRID-ORCS; 27247; 89 hits in 1157 CRISPR screens.
DR   ChiTaRS; NFU1; human.
DR   EvolutionaryTrace; Q9UMS0; -.
DR   GenomeRNAi; 27247; -.
DR   Pharos; Q9UMS0; Tbio.
DR   PRO; PR:Q9UMS0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9UMS0; protein.
DR   Bgee; ENSG00000169599; Expressed in heart right ventricle and 204 other cell types or tissues.
DR   ExpressionAtlas; Q9UMS0; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:FlyBase.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IDA:UniProtKB.
DR   GO; GO:0051604; P:protein maturation; IDA:FlyBase.
DR   FunFam; 3.30.300.130:FF:000001; NFU1 iron-sulfur cluster scaffold; 1.
DR   FunFam; 3.30.1370.70:FF:000002; NFU1 iron-sulfur cluster scaffold homolog, mitochondrial; 1.
DR   Gene3D; 3.30.300.130; Fe-S cluster assembly (FSCA); 1.
DR   Gene3D; 3.30.1370.70; Scaffold protein Nfu/NifU, N-terminal domain; 1.
DR   InterPro; IPR034904; FSCA_dom_sf.
DR   InterPro; IPR014824; Nfu/NifU_N.
DR   InterPro; IPR036498; Nfu/NifU_N_sf.
DR   InterPro; IPR001075; NIF_FeS_clus_asmbl_NifU_C.
DR   PANTHER; PTHR11178; IRON-SULFUR CLUSTER SCAFFOLD PROTEIN NFU-RELATED; 1.
DR   PANTHER; PTHR11178:SF1; NFU1 IRON-SULFUR CLUSTER SCAFFOLD HOMOLOG, MITOCHONDRIAL; 1.
DR   Pfam; PF08712; Nfu_N; 1.
DR   Pfam; PF01106; NifU; 1.
DR   SMART; SM00932; Nfu_N; 1.
DR   SUPFAM; SSF117916; Fe-S cluster assembly (FSCA) domain-like; 1.
DR   SUPFAM; SSF110836; Hypothetical protein SAV1430; 1.
DR   neXtProt; NX_Q9UMS0; -.
DR   PharmGKB; PA162397454; -.
DR   TreeFam; TF315076; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Disease variant;
KW   Hereditary spastic paraplegia; Iron; Iron-sulfur; Metal-binding;
KW   Mitochondrion; Neurodegeneration; Primary mitochondrial disease;
KW   Proteomics identification; Reference proteome; Transit peptide.
FT   TRANSIT         1..9
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           10..254
FT                   /note="NFU1 iron-sulfur cluster scaffold homolog,
FT                   mitochondrial"
FT                   /id="PRO_0000166191"
FT   REGION          173..241
FT                   /note="NifU"
FT   BINDING         210
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000305|PubMed:27818104"
FT   BINDING         213
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000305|PubMed:27818104"
FT   VAR_SEQ         1..141
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041224"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10810093,
FT                   ECO:0000303|PubMed:11342215, ECO:0000303|PubMed:12886008"
FT                   /id="VSP_041225"
FT   VARIANT         21
FT                   /note="R -> P (in MMDS1; patient's skeletal muscles and
FT                   fibroblasts show deficiency of mitochondrial respiratory
FT                   chain complexes; dbSNP:rs776875884)"
FT                   /evidence="ECO:0000269|PubMed:25918518"
FT                   /id="VAR_079757"
FT   VARIANT         25
FT                   /note="M -> K (in dbSNP:rs4453725)"
FT                   /evidence="ECO:0000269|PubMed:12915448,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_044429"
FT   VARIANT         88
FT                   /note="F -> S (in SPG93; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_089997"
FT   VARIANT         99
FT                   /note="L -> V (in SPG93; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_089998"
FT   VARIANT         100
FT                   /note="A -> P (in SPG93; uncertain significance;
FT                   dbSNP:rs1279585557)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_089999"
FT   VARIANT         101
FT                   /note="R -> G (in SPG93; uncertain significance;
FT                   dbSNP:rs2104792930)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090000"
FT   VARIANT         121
FT                   /note="V -> A (in SPG93; likely pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090001"
FT   VARIANT         133
FT                   /note="L -> P (in SPG93; uncertain significance;
FT                   dbSNP:rs770896590)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090002"
FT   VARIANT         182
FT                   /note="R -> W (in MMDS1; patient's skin fibroblasts show
FT                   deficiency of lipoic acid synthase and reduced lipoic acid
FT                   content; dbSNP:rs1354126704)"
FT                   /evidence="ECO:0000269|PubMed:25918518"
FT                   /id="VAR_079758"
FT   VARIANT         183
FT                   /note="P -> R (in SPG93; likely pathogenic;
FT                   dbSNP:rs1156891721)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090003"
FT   VARIANT         189
FT                   /note="G -> R (in MMDS1 and SPG93; pathogenic; alters
FT                   protein structure; increases likelihood of existing as
FT                   monomer; decreases ability to receive a Fe/S clusters from
FT                   donor proteins; decreases delivery rates of [2Fe-2S]
FT                   cluster to target proteins; dbSNP:rs2104735490)"
FT                   /evidence="ECO:0000269|PubMed:25477904,
FT                   ECO:0000269|PubMed:25918518, ECO:0000269|PubMed:28906594,
FT                   ECO:0000269|PubMed:36256512"
FT                   /id="VAR_079759"
FT   VARIANT         190
FT                   /note="G -> R (in MMDS1; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:25918518"
FT                   /id="VAR_079760"
FT   VARIANT         208
FT                   /note="G -> C (in MMDS1; patient's skeletal muscles and
FT                   fibroblasts show deficiency of mitochondrial respiratory
FT                   chain complexes; increases homodimerization; unable to
FT                   receive a Fe/S clusters from donor proteins; changes
FT                   delivery rates of [2Fe-2S] cluster to target proteins;
FT                   dbSNP:rs374514431)"
FT                   /evidence="ECO:0000269|PubMed:22077971,
FT                   ECO:0000269|PubMed:25918518, ECO:0000269|PubMed:28161430"
FT                   /id="VAR_066639"
FT   VARIANT         210
FT                   /note="C -> F (in MMDS1 and SPG93; likely pathogenic;
FT                   dbSNP:rs201634470)"
FT                   /evidence="ECO:0000269|PubMed:25477904,
FT                   ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090004"
FT   VARIANT         241
FT                   /note="V -> L (in SPG93; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:36256512"
FT                   /id="VAR_090005"
FT   MUTAGEN         189
FT                   /note="G->A: Alters protein structure. Increases likelihood
FT                   of existing as monomer. Decreases ability to receive a Fe/S
FT                   clusters from donor proteins. Decreases delivery rates of
FT                   [2Fe-2S] cluster to target proteins."
FT                   /evidence="ECO:0000269|PubMed:28906594"
FT   MUTAGEN         189
FT                   /note="G->K: Alters protein structure. Increases likelihood
FT                   of existing as monomer. Decreases ability to receive a Fe/S
FT                   clusters from donor proteins. Decreases delivery rates of
FT                   [2Fe-2S] cluster to target proteins."
FT                   /evidence="ECO:0000269|PubMed:28906594"
FT   CONFLICT        158
FT                   /note="S -> P (in Ref. 4; AAD27742)"
FT                   /evidence="ECO:0000305"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   STRAND          71..75
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   STRAND          80..83
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   HELIX           93..96
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   HELIX           98..103
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   STRAND          109..115
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   STRAND          118..125
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   HELIX           130..147
FT                   /evidence="ECO:0007829|PDB:2LTM"
FT   HELIX           167..188
FT                   /evidence="ECO:0007829|PDB:2M5O"
FT   STRAND          192..198
FT                   /evidence="ECO:0007829|PDB:2M5O"
FT   STRAND          201..206
FT                   /evidence="ECO:0007829|PDB:2M5O"
FT   TURN            208..212
FT                   /evidence="ECO:0007829|PDB:2M5O"
FT   HELIX           214..231
FT                   /evidence="ECO:0007829|PDB:2M5O"
FT   STRAND          237..240
FT                   /evidence="ECO:0007829|PDB:2M5O"
SQ   SEQUENCE   254 AA;  28463 MW;  E84B7F47A4A282CF CRC64;
     MAATARRGWG AAAVAAGLRR RFCHMLKNPY TIKKQPLHQF VQRPLFPLPA AFYHPVRYMF
     IQTQDTPNPN SLKFIPGKPV LETRTMDFPT PAAAFRSPLA RQLFRIEGVK SVFFGPDFIT
     VTKENEELDW NLLKPDIYAT IMDFFASGLP LVTEETPSGE AGSEEDDEVV AMIKELLDTR
     IRPTVQEDGG DVIYKGFEDG IVQLKLQGSC TSCPSSIITL KNGIQNMLQF YIPEVEGVEQ
     VMDDESDEKE ANSP
//
